Today: 23 January 2026
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Vivakor (VIVK) Stock Soars 40% on $40M Oil Deal – Bulls & Bears Debate What’s Next

Vivakor (VIVK) Stock Soars 40% on $40M Oil Deal – Bulls & Bears Debate What’s Next

Stock Price Jumps on Funding News Vivakor’s stock price is on a rollercoaster ride. After spending much of October trading in the $0.20 range, VIVK leapt 5.69% to $0.26 by the close of Thursday, Oct. 23 – and then skyrocketed to $0.37 in early pre-market trading on Oct. 24 Benzinga. The surge came immediately after Vivakor confirmed closing a major…
24 October 2025
····
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 24.10.2025

ENDEDLive coverage has endedEnded: October 26, 2025, 6:00 AM EDT Ripple Prime Officially Introduced as Hidden Road Rebrands to Global Prime Broker October 24, 2025, 1:18 PM EDT. Ripple has rebranded Hidden Road as Ripple Prime after the acquisition, positioning the group as the first to operate a global prime broker for crypto. With Brad Garlinghouse and founder Marc Asch…
24 October 2025
····
Qualigen (QLGN) Stock Rockets on Crypto Pivot – But Experts Warn It’s a Risky Bet

Qualigen (QLGN) Stock Rockets on Crypto Pivot – But Experts Warn It’s a Risky Bet

Stock Rally on Crypto News On Oct. 23, after the market close, Qualigen released a press statement announcing its BitGo partnership Globenewswire Stocktitan. In after-hours trading, that news sent QLGN skyrocketing: Benzinga reported a 62.6% jump after-hours (from $3.53 to about $5.74) Benzinga. The frenzy continued into Oct. 24: TipRanks noted the stock was up more than 100% pre-market on…
24 October 2025
····
Integer Holdings (NYSE: ITGR) Stock Plunges 37% on Revised Forecast – Key Takeaways

Integer Holdings Stock Plunges on Weak Forecast – Analysts Weigh In

Stock Slammed Despite Earnings Beat Integer’s stock performance over the past week has been dramatic. The share price soared into the $100+ range ahead of earnings (even hitting a 52-week low of ~$99 just weeks prior, then rebounding) Investing Investing. But all those gains were wiped out in one day when third-quarter results came out. On October 23, the company…
24 October 2025
····
Newmont Stock Skyrockets as Gold Rally Hits Record Highs – Will the Boom Continue?

Newmont’s Wild Ride: Gold Boom Propels Stock to Record Highs, Then Earnings Jolt – What’s Next for NEM?

Gold Rally Sends Newmont Soaring, Then Sliding Newmont – the world’s largest gold producer – has ridden 2025’s gold rush to staggering heights. Spot gold prices blasted past $4,000 per ounce for the first time ever in early October and kept climbing to about $4,381/oz at their peak ts2.tech ts2.tech. This “record-busting rally” has been driven by a perfect storm…
24 October 2025
···
Deckers Stock Tanks on Weak Forecast – Is a Rebound Coming?

Deckers Stock Crashes on Tepid Outlook – Is a Big Bounce Back Brewing?

Stock Performance & Recent Trend Deckers’ share price had been trading around the low-$100s in mid-October 2025. On Oct. 23, 2025 it closed at about $102.54 ts2.tech. Trading volumes spiked into the millions on that day (roughly 8.8M shares, well above normal), as investors braced for earnings. Early on Oct. 23, DECK was up slightly for the week, but the big…
24 October 2025
····
Scienture Holdings (SCNX) Stock Skyrockets on FDA Drug Launch – Will the Rally Last?

Scienture Shares Skyrocket 350% on FDA-Approved Drug Launch – What’s Next?

Scienture’s unprecedented Oct. 23 rally was driven by the commercial rollout of Arbli, its first revenue-generating product. The company’s press release on Oct. 23 confirmed that it began sales and shipped first customer orders for Arbli (losartan suspension), immediately triggering the Nasdaq surge Finviz. CEO/co-CEO Narasimhan Mani said the event “represents a major achievement for Scienture” in moving from development…
24 October 2025
····
NatWest Stock Rockets as Q3 Profit Soars – What’s Next for Investors?

NatWest Stock Rockets as Q3 Profit Soars – What’s Next for Investors?

Context and Details: NatWest Group (formerly RBS) reported that strong loan growth and fee income powered its Q3 results. Total income excluding one-offs hit ~£4.2bn Lse (+15.7% YoY) as mortgage and corporate lending expanded. Customer loans (ex-central-bank) grew by £4.4bn in the quarter Lse, and assets under management rose ~8%, bolstered by market gains. Notably, NatWest largely avoided the hefty…
24 October 2025
····
Shock Rally: Porsche Stock Climbs on CEO Shakeup & EV Innovations – Can the Upswing Last? (Oct 24, 2025)

Shock Rally: Porsche Stock Climbs on CEO Shakeup & EV Innovations – Can the Upswing Last? (Oct 24, 2025)

Market Movements and Stock Outlook Porsche’s stock has had a volatile 2025. After peaking above €70 early in the year (on a brief EV hype), the shares slumped on profit warnings and macro pressures. The late-September guidance cut (profit margin to ~2%) knocked the shares about 7% lower in one day Reuters, trimming much of its year’s gains. Since then,…
24 October 2025
···
Lloyds Share Price: Can the FTSE‑100 Bank’s Value Keep Surging or Is a Crash Coming?

Lloyds Stock Soars 50% in 2025, Hits Decade High – Can It Survive £2bn Scandal?

Stock Rally and Current Price Lloyds Banking Group (LSE: LLOY) shares have surged ~50% in 2025, hitting 10‑year highs. In mid‑Oct, LLOY traded ~86–87p – not seen since before the 2016 Brexit vote ts2.tech ts2.tech. By 24 Oct they were around 84–85p. The rally has far outpaced the FTSE‑100, making Lloyds one of the year’s standout performers ts2.tech ts2.tech. Analysts attribute…
24 October 2025
··
1 … 341 342 343 344 345 … 583

Stock Market Today

  • Davide Campari-Milano Stock Forecast 2026-2030: Analyst Price Targets and Market Outlook
    January 23, 2026, 10:28 AM EST. Davide Campari-Milano (CPR) trades near €5.80 as of 16 January 2026, with steady intraday fluctuations amid ongoing portfolio streamlining and balance-sheet initiatives. Analysts forecast a moderate upside within 12 months, with average price targets ranging from €6.86 to €7.05 across MarketScreener, Fintel, and TradingView. The forecasts reflect expected valuation adjustments based on the company's focus on core brands and geographic expansion, while broader European market trends and earnings updates also influence estimates. Price targets span a wide range, from lows around €4.20 to highs up to €11.55, indicating diverse views on the stock's potential.
Go toTop